Affiliation: Johns Hopkins University
- Polyomavirus-associated nephropathy: a comparison of 2 different strategies for immunosuppression reductionDuvuru Geetha
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224 2780, USA
Medicine (Baltimore) 90:296-302. 2011..Post-PVAN rejection leads to graft failure. Early repeat allograft biopsy should be considered in the management of PVAN with persistent graft dysfunction...
- Results of repeat renal transplantation after graft loss from BK virus nephropathyDuvuru Geetha
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Transplantation 92:781-6. 2011..The aims of this study are to (1) describe the management of patients undergoing retransplantation after allograft loss in the setting of BKVN and (2) to identify risk factors for BK virus replication in the retransplant...
- Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplantChristine Murakami
Department of Medicine, Division of Nephrology, Johns Hopkins University, Baltimore, MD, USA
Transpl Int 26:1225-31. 2013..Follow-up biopsies (n = 3) showed resolution of active GN in two patients and persistent active GN in one patient. RTX is an alternative to CYC for remission induction in recurrent AAV-associated GN in KTX patients...
- Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsyDuvuru Geetha
Division of Nephrology, Johns Hopkins Bayview Medical Center, 301 Mason Lord Drive, Room 2509, Baltimore, MD 21224, USA
J Rheumatol 39:1413-7. 2012..In patients who are in apparent clinical remission, presence of persistent or new-onset microscopic hematuria may reflect active vasculitis, damage, or other glomerular pathology...
- Ureteral stents: a novel risk factor for polyomavirus nephropathyAbraham Thomas
Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD 21224, USA
Transplantation 84:433-6. 2007..Our findings reveal that the presence of a ureteral stent is associated with an increase in the risk of PVN...
- Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccinationTanu Duggal
Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD, USA
Am J Nephrol 38:174-8. 2013..Administration of influenza vaccines has been associated with the development of autoantibodies and autoimmune rheumatic disease...
- Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experienceDuvuru Geetha
Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
Transplantation 91:1370-5. 2011..We report our experience with AAV patients who underwent KTX at our institutions between 1996 and 2010. Median follow-up was 64 months...
- Advances in therapy for ANCA-associated vasculitisDuvuru Geetha
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Curr Rheumatol Rep 14:509-15. 2012..For patients with life-threatening disease, plasma exchange may be an effective adjuvant therapy. This article reviews seminal studies from the past decade that have contributed to the current standard of care...
- Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective studyRebecca L Manno
Division of Rheumatology, Johns Hopkins Vasculitis Center, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle, Room 1B 13, 21224, Baltimore, MD, USA
BMC Nephrol 16:88. 2015..The aim of this study was to describe a retrospective cohort of older patients with AAV and severe renal involvement which required hemodialysis...
- Rituximab for treatment of severe renal disease in ANCA associated vasculitisDuvuru Geetha
Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
J Nephrol 29:195-201. 2016..Rituximab (RTX) is approved for remission induction in ANCA associated vasculitis (AAV). However, data on use of RTX in patients with severe renal disease is lacking...
- Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcomeCarla L Ellis
Medicine, The Johns Hopkins Hospital and School of Medicine, Baltimore, Maryland, USA
BMC Nephrol 14:210. 2013..The goal of our study was to apply the proposed classification system to a United States cohort of vasculitis patients and determine the association of IWGRP class with estimated glomerular filtration rate (eGFR) at one year...
- Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritisPurva Sharma
Johns Hopkins Medical Institutions, Baltimore, MD, USA
Am J Kidney Dis 60:157-9. 2012..As exemplified by this case, it is important to consider fibrillary GN in the differential diagnosis of crescentic GN with linear immunoglobulin G deposits within the GBM. Electron microscopy is crucial to make this diagnosis...
- Clinical excellence in nephrology: Examples from the published literatureDuvuru Geetha
Department of Medicine, Johns Hopkins Bayview Medical Center, Johns Hopkins University, 301 Mason Lord Drive, Baltimore, MD, 21224, USA
BMC Nephrol 16:141. 2015..Relating the definition of clinical excellence to renal medicine is worthwhile in that it can help to exemplify the model to which physicians and trainees may seek to aspire...
- A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritisShivani Shah
Division of Nephrology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA
Clin Rheumatol 35:953-60. 2016..Although ANCA-negative patients present with lower eGFR and more interstitial fibrosis, 1-year and long-term outcomes in both groups are similar. ..
- Clinical characteristics and outcome of pauci-immune glomerulonephritis in African AmericansDuvuru Geetha
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md Electronic address
Semin Arthritis Rheum 43:778-83. 2014..Pauci-immune glomerulonephritis is rare in African Americans (AA) and the clinical presentation and treatment outcomes of vasculitis have not been well described...
- Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipientsAdnan Sharif
Renal Institute of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom
Clin J Am Soc Nephrol 7:1320-7. 2012..BKVAN link to rejection and graft accommodation phenotype were also explored. The Johns Hopkins Institutional Review Board approved this study...
- Renal transplant in Wegener's granulomatosis compared to microscopic polyangiitisDuvuru Geetha
Division of Nephrology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Rheumatol 37:1705-8. 2010..Antineutrophil cytoplasmic antibody-associated vasculitis is an important cause of endstage renal disease. Our aim was to investigate how the underlying vasculitis diagnosis may influence outcomes following renal transplant...
- Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agentDuvuru Geetha
Department of Medicine, The Johns Hopkins Hospital Medical Institutions, Baltimore, Maryland 21231, USA
Transplantation 73:1933-6. 2002..High level expression of BKV large T antigen in the primary and metastatic carcinoma, but not in the nonneoplastic urothelium, implicates BKV as an etiologic agent in the development of this tumor...